Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Reni

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
World Journal of Gastroenterology|June 13, 2012
Adjuvant treatment in biliary tract cancer: to treat or not to treat?Stefano Cereda, Carmen Belli, Michele Reni
World Journal of Gastroenterology|September 13, 2012
Role of taxanes in pancreatic cancerCarmen Belli, Stefano Cereda, Michele Reni
JAMA Oncology|October 6, 2022
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?Michele Reni, Marina Macchini, Giulia Orsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas?Michele Reni, Andrés J M Ferreri
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Establishing a prognostic score for primary CNS lymphomasAndrés J M Ferreri, Michele Reni
Cancer Treatment Reviews|September 5, 2017
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategiesMarta Chiaravalli, Michele Reni, Eileen M O'Reilly
Critical Reviews in Oncology/Hematology|May 8, 2007
EpendymomaMichele Reni, Gemma Gatta, Elena Mazza, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Current therapeutic approaches to primary CNS lymphomaAndrés J M Ferreri, Stefania Dell'Oro, Michele Reni
Cancer Treatment Reviews|November 6, 2012
Neoadjuvant therapy in resectable pancreatic cancer: a critical reviewCarmen Belli, Stefano Cereda, Santosh Anand, et al.
Expert Opinion on Pharmacotherapy|September 16, 2015
Present and future treatment options for primary CNS lymphomaGiovanni Citterio, Michele Reni, Andrés José Maria Ferreri
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
World Journal of Gastroenterology|June 13, 2012
Adjuvant treatment in biliary tract cancer: to treat or not to treat?Stefano Cereda, Carmen Belli, Michele Reni
World Journal of Gastroenterology|September 13, 2012
Role of taxanes in pancreatic cancerCarmen Belli, Stefano Cereda, Michele Reni
JAMA Oncology|October 6, 2022
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?Michele Reni, Marina Macchini, Giulia Orsi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Is withdrawal of consolidation radiotherapy an evidence-based strategy in primary central nervous system lymphomas?Michele Reni, Andrés J M Ferreri
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Establishing a prognostic score for primary CNS lymphomasAndrés J M Ferreri, Michele Reni
Cancer Treatment Reviews|September 5, 2017
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategiesMarta Chiaravalli, Michele Reni, Eileen M O'Reilly
Critical Reviews in Oncology/Hematology|May 8, 2007
EpendymomaMichele Reni, Gemma Gatta, Elena Mazza, et al.
Expert Review of Neurotherapeutics|October 9, 2009
Current therapeutic approaches to primary CNS lymphomaAndrés J M Ferreri, Stefania Dell'Oro, Michele Reni
Cancer Treatment Reviews|November 6, 2012
Neoadjuvant therapy in resectable pancreatic cancer: a critical reviewCarmen Belli, Stefano Cereda, Santosh Anand, et al.
Expert Opinion on Pharmacotherapy|September 16, 2015
Present and future treatment options for primary CNS lymphomaGiovanni Citterio, Michele Reni, Andrés José Maria Ferreri
Pageof 24